Monitoring of circulating tumor DNA predicts response to treatment and early progression in follicular lymphoma: results of a prospective pilot study.
Ismael Fernández-MirandaLucía PedrosaMarta LlanosFernando F FrancoSagrario GómezPaloma Martín-AcostaFrancisco R García-ArroyoJosep Gumà PadróBeatriz HorcajoAna K BallesterosLaura Gálvez CarvajalNatividad Martínez-BanaclochaMiguel MarínSilvia SequeroMarta NavarroNatalia Yanguas-CasásVirginia CalvoAntonio Rueda DomínguezMariano Provencio PullaMargarita Sánchez-BeatoPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Basal ctDNA levels are associated with the risk of early progression and response to treatment in FL. cfDNA monitoring and genotyping during treatment and follow-up predict response to treatment and early progression.